Abstract:Apocynin, a potent inhibitor of NADPH-oxidase, was widely studied for activities in diseases such as inflammation-mediated disorders, asthma and cardiovascular diseases. In our recent study, a novel nitrone derivative of apocynin, AN-1, demonstrated potent inhibition to oxidative injury and to high expression of gp91(phox) subunit of NADPH-oxidase induced by tert-butyl hydroperoxide (t-BHP) in RAW 264.7 macrophage cells, and displayed promising preclinical protective effect against lipopolysaccharide (LPS)-induced acute lung injury in rats. In this work, the pharmacokinetic behaviors of AN-1 in Sprague-Dawley rats with single intravenous and intragastric doses were investigated for further development. Furthermore, apocynin's pharmacokinetics remain lacking, even though its pharmacological action has been extensively evaluated. The pharmacokinetics of parent apocynin were also comparatively characterized. A simple HPLC method was developed and validated to determine both AN-1 and apocynin in rat plasma. The chromatographic separation was achieved on an Agilent HC-C18 column (250 mmx4.6 mm, 5 mu m) at an isocratic flow rate of 1.0 mL/min, with the mobile phase of methanol and water (53:47, v/v) and the UV detection set at 279 nm. Good linearity was established over the concentration range of 0.1-500 mu g/mL for AN-1 and 0.2-100 mu g/mL for apocynin. The absolute recovery, precision and accuracy were satisfactory. Compared with the parent compound apocynin, AN-1 yielded a much longer T-1/2 (AN-1 179.8 min, apocynin 6.1 min) and higher AUC(0-t) (AN-1 61.89 mmol/L.min, apocynin 2.49 mmol/L.min) after equimolar intravenous dosing (0.302 mmol/kg). The absolute bioavailability of oral AN-1 was 78%, but that of apocynin was only 2.8%. The significant improvement of pharmacokinetic behavior might be accounted for the effective pharmacodynamic results we documented for the novel nitrone derivative AN-1.

Synthesis of Novel Apocynin Dimer Derivatives

NADPH Oxidase Inhibition of Novel Apocynin Dimer Derivatives

Synthesis and biological evaluations of novel apocynin analogues.

Improvement Of Pharmacokinetics Behavior Of Apocynin By Nitrone Derivatization: Comparative Pharmacokinetics Of Nitrone-Apocynin And Its Parent Apocynin In Rats

Nitrogen-Containing Apigenin Analogs: Preparation And Biological Activity

Pharmacology of apocynin: a natural acetophenone

A Model of Interaction Between Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase and Apocynin Analogues by Docking Method.

Bioavailability of apocynin through its conversion to glycoconjugate but not to diapocynin.

Exploring Aporphine as Anti-inflammatory and Analgesic Lead from Dactylicapnos scandens

Concise Synthesis of (+)-Β- and Γ-Apopicropodophyllins, and Dehydrodesoxypodophyllotoxin

The synthesis and bioactivity of apigenin derivatives

A Novel Synthesis Method of Apogossypolone and Its Antitumor Activity

Synthesis and antifungal activities of novel nicotinamide derivatives containing 1,3,4-oxadiazole

Synthesis and Biological Evaluation of Apigenin Derivatives as Antibacterial and Antiproliferative Agents

Novel Anticancer Oridonin Derivatives Possessing a Diazen-1-ium-1,2-diolate Nitric Oxide Donor Moiety: Design, Synthesis, Biological Evaluation and Nitric Oxide Release Studies.

Design, Synthesis, and Biological Evaluation of Quinoline (Quinolinone) Derivatives as NADPH Oxidase (NOX) Inhibitors

Synthesis of Nicotinc Acid Coupled with Nitric Oxide Donors

Apigenin Bioisosteres: Synthesis and Evaluation of their Antioxidant, Antimicrobial, and Anticancer Activities

Distribution of Apocynin and Its Glycosides in Plant Kingdom and Its Pharmacological Research Progress

Synthesis, nitric oxide release, and α-glucosidase inhibition of nitric oxide donating apigenin and chrysin derivatives.

Influence of Ortho Group Introduction on the Alkylation of Phenolic Hydroxyl of Apocynin